Five isolates of hepatitis C virus (HCV) RNA from patients with chronic liver disease in Nepal were not classifiable into the known genotypes I/la, II/lb, II1/2a, IV/2b or V/3a using PCR with type-specific primers deduced from the HCV core gene. Their nucleotide sequences were determined for the 5'-terminal 1.5 kilobases and 3'-terminal 1.2 kilobases, covering 30 % of the entire genome, and compared with each other and with reported sequences of HCV isolates of various genotypes. They were more similar to a reported HCV isolate (NZL1) of genotype V/3a (in 81.6 to 84.1% of their nucleotides and 85"7 to 88.7% of the deduced amino acid sequence) compared with the genotypes I/la to IV/2b (in 69.3 to 74.7% and 72'3 to 77.4%, respectively). Hence they were considered to be variants of the third major group (group 3). The five HCV isolates shared 81.3 to 85.2% of nucleotide sequence and 85.4 to 89.3 % of deduced amino acid sequence. Thus they were substantially different from each other. One of them was classified as genotype Vl/3b due to an 88-2 % similarity in nucleotide sequence to that of the reported HCV isolates of this genotype, whereas the remaining four were classified into provisional genotypes 3c, 3d, 3e and 3f. These HCV variants have evolved and remained in Nepal, and have not been observed in the other areas of the world.
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Hepatitis C virus (HCV) has a positive-stranded RNA of about 9400 nucleotides (nt) , and is the major aetiological agent of acute and chronic non-A, non-B liver diseases (Alter et aL, 1989) . As sequence data accumulate on many HCV isolates, a wide range of variability in the HCV genome is becoming apparent. Based on sequence similarity in the entire genome and within parts thereof, HCV isolates are classified into genotypes I, II, III, IV, V and V! (Mori et al., 1992; Okamoto et al., 1992b Okamoto et al., , d, 1993 . Another nomenclature for the classification of HCV is proposed which defines three major types, 1, 2 and 3, with each type being divided into two subtypes, a and b (Chan et al., 1992;  The nucleotide sequence data reported in this paper have been deposited in the DDBJ, GenBank and EMBL databases under the following accession numbers: the 5'-terminal 1504 to 1505 nucleotides and the 3'-terminal 1141 to 1154 nucleotides for the NE137 isolate (genotype VI/3b) nos. D16616 and D16617, respectively: those for NE048 (3c) nos. D16612 and D16613; those for NE274 (3d) nos. D16620 and D16621 ; those for NE145 (3e) nos. D16618 and D16619; those for NE125 (3/) nos. D166t4 and D16615. Simmonds et al., 1993; Stuyver et al., 1993) . Genotype I corresponds to la, II to lb, III to 2a, IV to 2b, V to 3a and VI to 3b. In this paper, we use both nomenclatures to reflect current provisional classifications.
In a survey of HCV markers occurring in 145 patients with chronic liver disease in Nepal, 12 sera were positive for HCV RNA by PCR with nested primers deduced from well conserved areas of the 5' untranslated region (UTR) of the HCV genome (Okamoto et al., 1990; Nagayama et al., 1993) . When they were genotyped by PCR with primers specific to the core gene of one or other genotypes I/la, II/lb, III/2a, IV/2b and V/3a (Okamoto et al., 1992d , one was found to be of genotype I/la, five of II/lb and one of V/3a. The remaining five were not classifiable into any of these genotypes.
Nucleic acids were extracted from 0" 1 to 1 "0 ml of the five untypable sera and reverse-transcribed to cDNA with HCV-specific 20-mer primers (nos. 122 and 337) or a non-specific 43-mer primer (no. 165) with (A)17 as described previously (Okamoto et al., 1992b (Okamoto et al., , d, 1993 . A Y-terminal fragment spanning nt 63 to 847 (785 nt); (Okamoto et al., 1990 (Okamoto et al., , 1992b ) (nucleotides are numbered from the putative 5' end of the genome of HCV genotype II/lb for which the entire sequence has been determined by Okarnoto et al., 1992c) .
For each of the five RNAs, three cDNA clones of both plus and minus strands were sequenced for the three regions, and the consensus sequences were determined. They covered 1504 or 1505 nt of the 5'-terminal sequence and 1141 to 1154 nt of the 3'-terminal sequence. Together they accounted for approximately 30% of the entire genome, including the 3'-terminal 259 or 260 nt (76 %) of the 5' UTR (341 nt, nt 1 to 341), all 573 nt of the core gene (nt 342 to 914), all 576 nt of the E1 gene (nt 915 to 1490), 96 nt (9%) including a hypervariable region (Hijikata et al., 1991 ; Weiner et al., 1991) of the E2/NS1 region (1038 nt, nt 1491 to 2528), 1096 nt (37 %) of the NS5 region (2991 nt, nt 6381 to 9371) and the entire 3' UTR excluding the poly(T) tail. Table 1 compares the nt and deduced amino acid (aa) sequences of the five HCV isolates of unclassifiable genotypes from Nepal. For the reasons given below, they were designated and classified provisionally as follows: * The five HCV isolates of novel genotypes from Nepal were compared within the indxcated regions for the similarity of nucleotide sequence and amino acid sequence (in parentheses). The figures indicate ranges of similarity.
"~ The four HCV isolates of different genotypes with the entire sequence known are HC-J1 (Okamoto et aL, 1992a) , HC-J4/83 (Okamoto et aL, 1992c) , HC-J6 (Okamoto et aL, 1991) and HC-J8 (Okamoto et al., 1992 b) with database accession nos. D 10749, DO 1217, D00944 and D01221, respectively. NE137 in subgroup VI/3b of the major group 3, NE048 in subgroup 3c, NE274 in 3d, NE145 in 3e and NE125 in 3f. They showed > 95.8 % similarity in the 5' UTR; two isolates (NE274 and NE125) had an insertion of A after nt 121 that has not been observed in any reported isolate. They shared > 80 % of the 3' UTR sequence which varies extensively among reported isolates of different genotypes (Okamoto et at., 1992b . Within the coding regions, the similarity of nt sequence in the core gene ranged from 85.0 to 90"4 %, that in the E1 gene 71-7 to 77.1%, and that in the NS5 region 82.2 to 87.2%. A Y-terminal sequence of the E2/NS1 region, including a hypervariable region, was most variable with a similarity of only 44.8 to 61.5 %. The similarity in a total of 2625 nt ranged from 81.3 to 85.2% and that in the deduced 779 aa from 85.4 to 89.3 %. The five HCV isolates from Nepal were compared with four HCV isolates of genotype I/la, II/lb, III/2a or IV/2b, for which the entire genomic sequences are known ( Table 2 ). The five isolates were similar to the four isolates of genotypes I/1 a to IV/2b in 69"3 to 74.7 % of the 5'-and 3"-terminal sequences spanning 2625 nt. The sequence similarity of the five isolates from Nepal to the four HCV isolates of genotypes I/la to IV/2b, therefore, was less than that within themselves. These results indicated that the five HCV isolates from Nepal were related but significantly different from each other, and that they were not of genotypes I/la to IV/2b. Tables 2 and 3 The five HCV isolates from Nepal were compared with reported HCV isolates of genotypes other than I/la to IV/2b, for which only partial sequences are available (Table 3) . Within the coding regions, they were > 77 % similar in nt sequence to isolates of genotype V/3a. One isolate (NE137) was > 90 % similar to HCV isolates of genotype VI/3b (T-9 and T-10) within a part of the NS5 region (334 nt) and 88.2 % similar to another isolate of the same genotype (HPCENCR) within a 5'-terminal sequence of 1504 nt. NE 137 was considered, therefore, to be of genotype VI/3b. Because both genotypes V/3a and VI/3b are of the third major group, the five HCV isolates from Nepal would belong to group 3. Substantial sequence divergence among them indicated that they should be classified into distinct subgroups of group 3. Therefore, the NE137 isolate is considered to be of genotype VI/3b, and genotypes of the remaining four isolates were provisionally designated 3c for the NE048 isolate, 3d for NE274, 3e for NE145 and 3f for NE125.
The five isolates from Nepal shared only 77"0 to 82.6 % of a core gene sequence of 242 or 226 nt with HCV isolates from Egypt, which are proposed to be of type 4 by Simmonds et al. (1993) . They showed a similarity of 90.9 to 94.6 % in a 5' UTR sequence to HCV isolates of unclassified genotypes from various areas of the world (Bukh et al., 1992) , which is substantially less than the value of 95.8 to 98.8 % among themselves. Hence, the five Table 3 for accession nos. of HCV isolates.
isolates from Nepal are of previously unclassified genotypes.
The sequence divergence characteristic of genotypes I/1 a to IV/2b is distributed over the entire HCV genome, with variations most extensive in the E1 and NS2 genes (Okamoto et al., 1992b) . In Fig. 1 a phylogenetic tree of HCV has been constructed based on the difference in nt sequence within the entire E1 gene by using the unweighted pair-group method with arithmetic mean (Nei & Gojobori, 1986) . This analysis further substantiated the subgrouping of group 3 (3b to 3f) to which the five HCV isolates from Nepal would belong.
Genotypes V/3a and VI/3b were proposed originally because of the sequence divergence within a part of the NS5 region (Mori et al., 1992) . Fig. 2 depicts a phylogenetic tree constructed with 13 HCV isolates of group 3 for which an NS5 region sequence of 334 nt (nt 8366 to 8699) is available for comparison. The tree shows differences as well as relatedness among the 13 HCV isolates of group 3, and reinforces the novel subgrouping of type 3.
In this analysis some characteristics of HCV isolates of group 3 became apparent, which are not shared by those of genotypes I/la to IV/2b. HCV isolates of genotypes I/la to IV/2b invariably have two in-phase stop codons in the 3" UTR (Okamoto et al., 1991) , contrasting with only one in those of genotype V/3a . This feature of group 3 was preserved in all the five HCV isolates from Nepal of genotypes VI/3b, 3c, 3d, 3e or 3f (Fig. 3) . The distance from the first stop codon to the poly(T) tail was 20 to 28 nt for isolates of subgroups V/3a, VI/3b, 3d and 3e, somewhat shorter than those of 3c and 3fwith 37 and 39 nt, respectively, or those of genotypes I/la to IV/2b with 38 to 42 nt.
Conserved secondary structures are recognized within a Y-terminal region of 300 nt of the HCV genome, and (Okamoto et al., 1992c) , HC-J6 of genotype III/2a (Okamoto et al., 1991) , HC-J8 of genotype IV/2b (Okamoto et al., 1992b) and NZL1 of genotype V/3a , as well as for the five HCV isolates from Nepal classifiable into subgroups of group 3 (3b to 3f). In-phase stop codons are shaded.
its role in the viral replication has been proposed (Han& Houghton, 1992) . In common with other isolates of genotype V/3a , all the five HCV isolates from Nepal, classified into subgroups of group 3 (3b to 3e), were devoid of the 3'-terminal one of the four stem and loop structures. Whether this influences the replication efficiency or pathogenicity of group 3 HCV would be of virological and clinical interest. Sequence analyses of the five HCV isolates of group 3 from Nepal revealed a range of sequence variability which allows their classification into at least five subgroups, 3b to 3t", and highlighted the unique character of HCV genomes of group 3. HCV isolates of genotypes 3c to 3f are different from any reported isolates from other parts of the world, and therefore appear to have evolved and remained in Nepal, a place that has been isolated geographically because of its high altitude and historically for many centuries. It remains to be seen whether these HCV genotypes have not only epidemiological significance, but also clinical differences in the severity of liver disease they induce and their response to interferon, as has been observed for other genotypes (Takada et al., 1992; Yoshioka et al., 1992) . Variations in amino acid sequence of viral proteins encoded by these RNAs should be considered in the serological diagnosis of HCV infection and the development of vaccines.
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